Investigation of direct toxic and teratogenic effects of anticoagulants on rat embryonic development using in vitro culture method and genotoxicity assay

Journal of Veterinary Medicine Series C: Anatomia Histologia Embryologia

Volumn 35, Issue 2, 2006, Pages 84-92

  Uysal, I I ^a   Karabulut, A K ^a   Ozdemir, K ^a   Aksoy, M ^a   Altunkeser, B B ^a   Acar, H ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANIMAL; ARTICLE; CONGENITAL MALFORMATION; DOSE RESPONSE; DRUG EFFECT; EMBRYO; EMBRYO CULTURE; IN VITRO STUDY; MICRONUCLEUS TEST; PRENATAL DEVELOPMENT; RAT; WISTAR RAT;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ANTICOAGULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO; EMBRYO CULTURE TECHNIQUES; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; MICRONUCLEUS TESTS; RATS; RATS, WISTAR;

EID: 33645000344     PISSN: 03402096     EISSN: 14390264     Source Type: Journal    
DOI: 10.1111/j.1439-0264.2005.00642.x     Document Type: Article

References (36)

1. Adler S. 1988 Inhibition of rat glomerular visceral epithelial cell growth by heparin Am. J. Physiol. Renal. Physiol. 255 781 786
2. Bainbridge S. A. E. H. Sidle G. N. Smith 2005 Direct placental effects of cigarette smoke protect women from pre-eclampsia: the specific roles of carbon monoxide and antioxidant systems in the placenta Med. Hypotheses. 64 17 27
3. Blomback M. K. Bremme M. Hellgren A. Siegbahn H. Lindberg 1998 Thromboprophylaxis with low molecular mass heparin, 'Fragmin' (dalteparin), during pregnancy-a longitudinal safety study Blood. Coagul. Fibrinolysis 9 1 9
4. Bouhours-Nouet N. P. May-Panloup R. Coutant F. B. de Casson P. Descamps O. Douay P. Reynier P. Ritz Y. Malthiery G. Simard 2005 Maternal smoking is associated with mitochondrial DNA depletion and respiratory chain complex III deficiency in placenta J. Physiol. Endocrinol. Metab. 288 171 177
5. Countryman P. J. Heddle 1976 The production of micronuclei from chromosome aberrations in irradiated cultures of human lymphocytes Mutat. Res. 41 321 332
6. Dimitrakakis C. P. Papageorgiou I. Papageorgiou A. Antzaklis N. Sakarelou S. Michalas 2000 Absence of transplacental passage of the low molecular weight heparin enoxaparin Haemostasis 30 243 248
7. Ensom M. H. M. D. Stephenson 1999 Low-molecular-weight heparins in pregnancy Pharmacotherapy 9 1013 1025
8. Fejgin M. D. D. L. Lourwood 1994 Low molecular weight heparins and their use in obstetrics and gynecology Obstet. Gynecol. Surv. 49 424 431
9. Forestier F. F. Daffos M. Rainaut F. Toulemonde 1987 Absence of transplacental passage of Fraxiparin (low molecular weight heparin) during the 3d trimester of pregnancy J. Gynecol. Obstet. Biol. Reprod. 16 981 986
10. Freeman S. J. F. Beck J. B. Lloyd 1981 The role of the visceral yolk sac in mediating protein utilization by rat embryos cultured in vitro J. Embryol. Exp. Morphol. 66 223 234
11. Ginsberg J. S. I. Greer J. Hirsh 2001 Use of antithrombotic agents during pregnancy Chest 119 122 131
12. Greer I. A. 2001 The acute management of venous thromboembolism in pregnancy Curr. Opin. Obstet. Gynecol. 13 569 575
13. Greer I. A. 2002 Exploring the role of low-molecular-weight heparins in pregnancy Semin. Thromb. Hemost. 28 25 31
14. Huang S. T. K. C. Vo D. J. Lyell G. H. Faessen S. Tulac R. Tinshirani A. J. Giaccia L. C. Giudice 2004 Developmental response to hypoxia FASEB J. 18 1348 1365
15. Kanaka-Gantenbein C. G. Mastorakos G. P. Chrousos 2003 Endocrine-related causes and consequences of intrauterine growth retardation Ann. N. Y. Acad. Sci. 997 150 157
16. Kesby G. J. 1992 In vitro development of rat embryos undergoing organogenesis in heparin-plasma Teratology 45 293 301
17. Kesby G. J. 2000 Toxicity of heparin in postimplantation whole-embryo culture Toxicol. App. Pharmacol. 163 60 66
18. Laurent P. G. V. Dussarat J. Bonal C. Jego P. Talard C. Bouchiat G. Cellarier 2002 Low molecular weight heparins: a guide to their optimum use in pregnancy Drugs 62 463 477
19. Leach L. C. Gray S. Staton M. O. Babawale A. Gruchy C. Foster T. M. Mayhew D. K. James 2004 Vascular endothelial cadherin and beta-catenin in human fetoplacental vessels of pregnancies complicated by Type 1 diabetes: associations with angiogenesis and perturbed barrier function Diabetologia 47 695 709
20. Lepercq J. J. Conard A. Borel-Derlon J. K. Darmon O. Boudignat C. Francoual P. Priollet C. Cohen N. Yvelin J. F. Schved M. Tournaire J. Y. Borg 2001 Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies B.J.O.G. 108 1134 1140
21. Lindhoff-Last E. H. Schinzel M. Erbe V. Schachinger R. Bauersachs 2001 Anticoagulation of pregnant women with mechanical heart valve prostheses Z. Kardiol. 6 125 130
22. Lowry O. H. N. J. Rosebrough A. L. Farr R. J. Randall 1951 Protein measurement with the folin phenol reagent J. Biol. Chem. 193 265 275
23. Meale G. V. F. F. Delhaise J. J. Picard 1990 Morphogenesis and quantification of the development of post-implantation mouse embriyos Toxicol. In Vitro. 4 149 156
24. Nelson-Piercy C. E. A. Letsky M. de Swiet 1997 Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk Am. J. Obstet. Gynecol. 176 1062 1068
25. Neufeld G. D. Gospodarowicz L. Dodge DK. Fujii 1987 Heparin modulation of the neurotropic effects of acidic and basic fibroblast growth factors and nerve growth factor on PC12 cells J. Cell. Physiol. 131 131 140
26. New D. A. T. 1978 Whole embryo culture and the study of mammalian embryos during organogenesis Biol. Review. 53 81 122
27. Pinni M. 1997 Low molecular weight heparin Recenti. Prog. Med. 88 594 602
28. Redline R. W. 2004 Placental inflammation Semin. Neonatol. 9 265 274
29. Rodie V. A. A. J. Thomson F. M. Stewart A. J. Quinn I. D. Walker I. A. Greer 2002 Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series B.J.O.G. 109 1020 1024
30. Samama M. M. G. T. Gerotziafas 2000 Comparative pharmacokinetics of LMWHs Semin. Thromb. Hemost. 26 31 38
31. Schinzel H. F. Bahlmann D. Peetz S. Savvidis L. Himmrich M. Klotz 2002 Prevention of thromboembolism with low molecular weight heparin (Dalteparin-Na) in risk pregnancy Med. Klin. 97 193 203
32. Tuckett F. G. M. Morriss-Kay 1989 Heparinitase treatment of rat embryos during cranial neurulation Anat. Embryol. 180 393 400
33. Ulander V. M. P. Stenqvist R. Kaaja 2002 Treatment of deep venous thrombosis with low-molecular-weight heparin during pregnancy Thromb. Res. 106 13 17
34. Vian L. N. Bichet D. Gouy 1993 The in vitro micronucleus test on isolated human lymphocytes Mutat. Res. 291 93 102
35. Webster W. S. W. N. A. Brown 1989 Teratogenic properties of heparin in rat whole embryo culture Teratology 40 259 (Abstract).
36. Wydra D. 2003 Morphometric analysis of the blood-placental barrier in pregnant women with hypertension Ginekol. Pol. 74 433 438